GSK
GSK launch sale of consumer healthcare brands
June 20, 2019Business Services GSK, Pfizer, consumer health, pharma, portfolio
British multinational GlaxoSmithKline (GSK) has launched a sale of some of its consumer healthcare brands. The sale comes as GSK …
Top Ten most popular articles on Pharmafile.com this week!
June 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma
Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …
GSK sets up new CRISPR lab with UC, Berkeley
June 13, 2019Medical Communications GSK, UC, berkely, crispr, genetics, pharma
GSK has struck a $67 million deal with the University of California, Berkeley. British multinational GlaxoSmithKline will collaborate with UC, …
Top Ten most popular articles on Pharmafile.com this week!
May 31, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA, GSK, Novartis, Pfizer, environment, opioids, pharma, pricing
The pharmaceutical industry is a big polluter than the automotive industry. This was our top story this week. The findings …
China approves GSK’s shingles vaccine Shingrix
May 24, 2019Medical Communications, Sales and Marketing China, GSK, Shingrix, pharma, shingles
GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the …
GSK to reintroduce bonuses for sales reps
May 24, 2019Medical Communications GSK, US, oncology, pharma, sales, sales reps, scandal
British multinational GlaxoSmithKline said on Thursday that it would reintroduce performance-based bonuses for some sales reps in some countries. The …
Top Ten most popular articles on Pharmafile.com this week!
May 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma
This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …
GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3
May 3, 2019Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma
GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …
GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus
April 30, 2019Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma
GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …
Top Ten most popular articles on Pharmafile.com this week!
April 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma
The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …
Innovative malaria vaccine to be trialled in Malawi
April 23, 2019Manufacturing and Production GSK, Mosquirix, RTS S, ghana, kenya, malaria, malawi
An innovative malaria vaccine is set to be trialled in Malawi as part of large scale trials which will see …
Top Ten most popular articles on Pharmafile.com this week!
April 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Genentech, Gilead, HIV, MS, Novartis, kidney disease, pharma
This week was a good one for clinical trials and a bad one for employees after both Gilead and GSK …
GSK to make redundancies at plant in Stevenage
April 17, 2019Research and Development GSK, GlaxoSmithKline, R&D, redundancies, stevenage
GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new …
ViiV Healthcares scores first twin-drug FDA approval for untreated HIV-1
April 9, 2019Manufacturing and Production, Research and Development GSK, HIV, ViiV Healthcare, pharma
ViiV Healthcare, the pharmaceutical firm owned by Shionogi, Pfizer and predominantly GSK, has announced its two-drug HIV regimen Dovato (dolutegravir …
Working Life: Dr Paul-Peter Tak, ex-Senior Vice President, Development Lead and Chief Immunology Officer at GSK, Venture Partner at Flagship Pioneering
March 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Working Life, feature
Dr Paul-Peter Tak, ex-Senior Vice President, Development Lead and Chief Immunology Officer at GSK, Venture Partner at Flagship Pioneering.How did …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
